DoD Kidney Cancer, Idea Development Award
ID: 355338Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355338
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Kidney Cancer Research Program (KCRP) Idea Development Award, aimed at funding innovative research projects that advance the understanding and treatment of kidney cancer. Applicants are encouraged to propose high-impact research with a well-defined hypothesis and methodology, focusing on areas such as basic biology, therapeutic development, and healthcare disparities, with an emphasis on benefiting military personnel, veterans, and the general public. The total estimated funding for this opportunity is approximately $18.56 million, with individual awards capped at $800,000 for single Principal Investigator (PI) projects and $1.2 million for Partnering PI projects, all applications due by October 15, 2024, following a pre-application submission by September 24, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524KCRPIDA_GG.pdf
    The DOD FY24 Kidney Cancer Idea Development Award seeks to fund innovative research with a focus on understanding, treating, and improving care for kidney cancer. The program allocates $50 million, aiming to support high-impact projects that benefit military personnel, veterans, and the public. Applications must address specific focus areas such as basic biology research, development of new therapeutic methods, enhancing patient care, and addressing healthcare disparities. The application process involves two steps: a pre-application submission due by September 24, 2024, followed by a full application by October 15, 2024. Eligible applicants include organizations and individuals affiliated with qualified institutions. The funding limits are set at $800,000 for single PI applications and $1.2 million for Partnering PI projects, both not exceeding a four-year term. Review criteria include the research strategy, innovation, impact, and the qualifications of the research team. Successful applications will demonstrate a strong scientific rationale, feasible methodologies, and the potential for significant contributions to kidney cancer research and patient care advancements. This funding opportunity underscores the government's commitment to fostering research that directly benefits those impacted by kidney cancer.
    Similar Opportunities
    DoD Kidney Cancer, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a funding opportunity for the Fiscal Year 2024 Kidney Cancer Research Program (KCRP) Clinical Trial Award, aimed at supporting innovative clinical trials that can significantly impact kidney cancer treatment and management. The program encourages proposals that range from preliminary proof-of-concept trials to large-scale studies, emphasizing the need for robust preliminary data, access to suitable patient populations, and necessary materials for the trials. With an estimated total program funding of $6.4 million and the expectation of awarding approximately two grants, interested applicants must submit a pre-application letter of intent by September 24, 2024, and a complete application by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Academy of Kidney Cancer Investigators – Leadership Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is inviting applications for the FY24 Kidney Cancer Academy of Kidney Cancer Investigators – Leadership Award under the Kidney Cancer Research Program (KCRP). This funding opportunity aims to support established kidney cancer researchers at the associate professor level or higher, focusing on enhancing research capacity, fostering collaboration, and mentoring early-career investigators in kidney cancer research. With an estimated total program funding of $2.4 million, the initiative seeks to award two cooperative agreements, with applications due by September 19, 2024, following a pre-application deadline of August 29, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Kidney Cancer, Translational Research Partnership Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Kidney Cancer Translational Research Partnership Award, a federal grant aimed at fostering collaborative research partnerships between clinicians and research scientists to advance kidney cancer treatment and care. This opportunity encourages the development of translational research projects that address significant problems in kidney cancer, requiring partnerships that include one clinician and one research scientist who contribute equally to the research design and execution. With an estimated total program funding of $7.68 million, the program anticipates awarding approximately six grants, each with a maximum budget of $800,000 over a three-year period. Interested applicants must submit a pre-application letter of intent by September 24, 2024, followed by a full application due by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Academy of Kidney Cancer Investigators - Early-Career Scholar Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Academy of Kidney Cancer Investigators - Early-Career Scholar Award, aimed at fostering innovative kidney cancer research by supporting early-career scholars. This program encourages applicants to develop research projects that address critical areas in kidney cancer biology, novel therapies, and healthcare disparities, while providing intensive mentoring and networking opportunities within a collaborative Academy environment. With an estimated total program funding of $2.32 million, the initiative anticipates awarding approximately two grants, with applications due by October 15, 2024, following a pre-application letter of intent due by September 24, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Idea Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Idea Award, a federal grant aimed at supporting innovative and high-risk cancer research relevant to military personnel, Veterans, and their families. This grant encourages proposals that challenge existing paradigms and explore new perspectives in cancer research, specifically excluding incremental advancements or ongoing projects. With an estimated total program funding of $16 million and the expectation of awarding approximately 20 grants, each project can receive up to $400,000 over a two-year period. Interested applicants must submit a pre-application by June 21, 2024, with full applications due later for those invited to proceed, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Cancer, Impact Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Impact Award, aimed at funding high-impact cancer research that benefits Service Members, Veterans, and their families. This grant opportunity seeks to support mature research projects that address critical cancer issues, with a focus on translational or clinical research that demonstrates the potential for significant near-term impact on patient outcomes. With an estimated total program funding of $16 million and the expectation of awarding approximately 10 grants, applicants must submit a pre-application by June 21, 2024, followed by a full application due by September 26, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 Rare Cancers Idea Development Award to support innovative research aimed at advancing the understanding and treatment of rare cancers. This grant opportunity encourages proposals that focus on understanding molecular pathways, developing tumor-specific models, or identifying novel therapies, with an emphasis on research that can significantly impact patient outcomes. The total funding available for this program is approximately $17.5 million, with individual awards capped at $350,000 over a three-year period, and applications are due in two stages: a pre-application by June 17, 2024, and a full application by September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DOD Pancreatic Cancer, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Pancreatic Cancer Research Program (PCARP) Idea Development Award, aimed at supporting innovative research projects that advance the understanding and treatment of pancreatic cancer. This grant opportunity encourages high-risk, high-reward studies that could lead to significant breakthroughs in early detection, supportive care, and the underlying mechanisms of pancreatic cancer, with a total estimated funding of $7.36 million available for approximately eight awards. Eligible applicants include both established and early-career investigators, with a maximum funding limit of $500,000 for single Principal Investigator (PI) applications and $650,000 for partnered applications, emphasizing the importance of collaboration in research efforts. Interested parties should note that the application deadline is October 3, 2024, with a pre-application deadline of June 28, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity titled "DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award" for Fiscal Year 2024. This funding initiative aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment and management, particularly for military personnel and their families, addressing specific topic areas related to military health. With an estimated total program funding of $24 million and the expectation of awarding up to five grants, eligible applicants can submit proposals that demonstrate the feasibility and relevance of their clinical trials, with a maximum award amount of $3 million. Interested parties must submit their applications by October 15, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Rare Cancers, Resource Community Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity, is offering the FY24 Rare Cancers Resource and Community Development Award to support research initiatives aimed at improving outcomes for individuals with rare cancers. This grant opportunity seeks to develop clinical or preclinical datasets and research resources that address significant gaps in rare cancer research, emphasizing collaboration among researchers, patients, and clinicians, with a mandatory inclusion of patient advocates in the project planning and implementation phases. With an estimated total funding of $6.4 million available for up to five awards, each project can receive a maximum of $800,000 over a four-year period. Interested applicants must submit a pre-application followed by a full application, with the submission deadline set for September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.